Abstract:Transforming growth factor-β (TGF-β) is a secreted multifunctional factor that plays a key role in intercellular communication. Perturbations of TGF-β signaling can lead to breast cancer. TGF-β elicits its effects on proliferation and differentiation via specific cell surface TGF-β type I and type II receptors (i.e., TβRI and TβRII) that contain an intrinsic serine/threonine kinase domain. Upon TGF-β-induced heteromeric complex formation, activated TβRI elicits intracellular signaling by phosphorylating SMAD2 and SMAD3. These activated SMADs form heteromeric complexes with SMAD4 to regulate specific target genes, including plasminogen activation inhibitor 1 (PAI-1, encoded by the SERPINE1 gene). The induction of epithelial-to-mesenchymal transition (EMT) allows epithelial cancer cells at the primary site or during colonization at distant sites to gain an invasive phenotype and drive tumor progression. TGF-β acts as a potent inducer of breast cancer invasion by driving EMT. Here, we describe systematic methods to investigate TGF-β signaling and EMT responses using premalignant human MCF10A-RAS (M2) cells and mouse NMuMG epithelial cells as examples. We describe methods to determine TGF-β-induced SMAD2 phosphorylation by Western blotting, SMAD3/SMAD4-dependent transcriptional activity using luciferase reporter activity and SERPINE1 target gene expression by quantitative real-time-polymerase chain reaction (qRT-PCR). In addition, methods are described to examine TGF-β-induced EMT by measuring changes in morphology, epithelial and mesenchymal marker expression, filamentous actin staining and immunofluorescence staining of E-cadherin. Two selective small molecule TGF-β receptor kinase inhibitors, GW788388 and SB431542, were used to block TGF-β-induced SMAD2 phosphorylation, target genes and changes in EMT marker expression. Moreover, we describe the transdifferentiation of mesenchymal breast Py2T murine epithelial tumor cells into adipocytes. Methods to examine TGF-β-induced signaling and EMT in breast cancer may contribute to new therapeutic approaches for breast cancer.

Dynamic Sialylation in Transforming Growth Factor-β (Tgf-Β)-induced Epithelial to Mesenchymal Transition

Visualizing Dynamic Changes During TGF-β-Induced Epithelial to Mesenchymal Transition.

Role of glycosylation in TGF-β signaling and epithelial-to-mesenchymal transition in cancer

Glycobiology of the Epithelial to Mesenchymal Transition

Type II Epithelial-Mesenchymal Transition Upregulates Protein N-Glycosylation To Maintain Proteostasis and Extracellular Matrix Production

Involvement of O-glycosylation defining oncofetal fibronectin in epithelial-mesenchymal transition process

Epigenetic Regulation of Epithelial to Mesenchymal Transition.

Regulation of Epithelial-to-Mesenchymal Transition Using Biomimetic Fibrous Scaffolds

Sialylation on vesicular integrin β1 determined endocytic entry of small extracellular vesicles into recipient cells

Abstract 204: Quantitative evaluation of biomarkers for TGF-β-induced epithelial-mesenchymal transition in biochemical, cellular, and 3D spheroid model systems

Inference of Intercellular Communications and Multilayer Gene-Regulations of Epithelial–Mesenchymal Transition From Single-Cell Transcriptomic Data

Mechanism of epithelial‐mesenchymal transition in cancer and its regulation by natural compounds

Sialylation: an Avenue to Target Cancer Cells

Novel regulatory mechanisms of N-glycan sialylation: Implication of integrin and focal adhesion kinase in the regulation

Transforms of Cell Surface Glycoproteins Charge Influences Tumor Cell Metastasis via Atypically Inhibiting Epithelial-Mesenchymal Transition Including Matrix Metalloproteinases and Cell Junctions

TGF-β-Mediated Epithelial-Mesenchymal Transition and Cancer Metastasis

Mechanotactic Activation of TGF‐β by PEDOT Artificial Microenvironments Triggers Epithelial to Mesenchymal Transition

Insights into the Role of Sialylation in Cancer Metastasis, Immunity, and Therapeutic Opportunity

Dynamic Chromatin Modification Sustains Epithelial-Mesenchymal Transition Following Inducible Expression of Snail-1

The basics of epithelial–mesenchymal transition (EMT): A study from a structure, dynamics, and functional perspective

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells.